Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus [0.03%]
2型糖尿病患者的非酒精性脂肪肝病(NAFLD)治疗
Paola Portillo-Sanchez,Kenneth Cusi
Paola Portillo-Sanchez
Nonalcoholic fatty liver disease (NAFLD) is believed to be the most common chronic liver disease, affecting at least one-third of the population worldwide. The more aggressive form is known as nonalcoholic steatohepatitis (NASH) and charact...
Prevalence of Gestational Diabetes Mellitus in urban and rural Tamil Nadu using IADPSG and WHO 1999 criteria (WINGS 6) [0.03%]
采用IADPSG和WHO 1999标准在城市和农村地区调查 tamil nadu孕妇妊娠期糖尿病患病率(WINGS 6)项目
Balaji Bhavadharini,Manni Mohanraj Mahalakshmi,Ranjit Mohan Anjana et al.
Balaji Bhavadharini et al.
Background: To determine the prevalence of Gestational Diabetes Mellitus (GDM) in urban and rural Tamil Nadu in southern India, using the International Association of Diabetes and Pregnancy Study Groups (IADPSG) and the W...
Ramesh Saeedi,Jiri Frohlich
Ramesh Saeedi
Epidemiological and genetic studies have identified elevated levels of lipoprotein (a) ((Lp(a)) as a causal and independent risk factor for cardiovascular diseases (CVD). The Lp(a)-induced increased risk of CVD may be mediated by both its p...
The role of chloramines in treatment of diabetic foot ulcers: an exploratory multicentre randomised controlled trial [0.03%]
氯胺治疗糖尿病足溃疡的疗效：多中心随机对照试验探索性研究
Karin Bergqvist,Ulrica Almhöjd,Irene Herrmann et al.
Karin Bergqvist et al.
Background: Chronic foot ulcers in diabetes are serious, costly and frequently difficult to heal. Recent guidelines conclude that new dressings and treatments generally fail to show superiority compared with standard of c...
Brief review: cell replacement therapies to treat type 1 diabetes mellitus [0.03%]
简评：治疗1型糖尿病的细胞替代疗法
Alberto Hayek,Charles C King
Alberto Hayek
Human embryonic stem cells (hESCs) and induced pluripotent cells (iPSCs) have the potential to differentiate into any somatic cell, making them ideal candidates for cell replacement therapies to treat a number of human diseases and regenera...
Thyroid dysfunction in metabolic syndrome patients and its relationship with components of metabolic syndrome [0.03%]
代谢综合征患者甲状腺功能异常及其与代谢综合征组分的关系
Saroj Khatiwada,Santosh Kumar Sah,Rajendra Kc et al.
Saroj Khatiwada et al.
Background: A growing body of evidence suggests that metabolic syndrome is associated with endocrine disorders including thyroid dysfunction. Thyroid dysfunction in metabolic syndrome patients may further add to cardiovas...
Tacrolimus toxicity in islet transplantation due to interaction with macrolides [0.03%]
他克莫司在胰岛移植中的毒性反应系与大环内酯类药物相互作用所致
Kitty Kit-Ting Cheung,Peter Alexander Senior
Kitty Kit-Ting Cheung
Background: Drug interactions are an important risk in transplant patients. Case presentation: This case describes an incident where a patient with islet transplantation, who was using tacrolimus as part of the immunosupp...
The Nurse Education and Transition (NEAT) model: educating the hospitalized patient with diabetes [0.03%]
糖尿病住院患者的护理教育和过渡模型(NEAT)
Jodi Stotts Krall,Amy Calabrese Donihi,Mary Hatam et al.
Jodi Stotts Krall et al.
Background: The number of patients with a diabetes mellitus (DM)-related diagnosis is increasing, yet the number of hospital-based diabetes educators is being reduced. Interest in determining effective ways for staff nurs...
Charcot stage 0: A review and consideratons for making the correct diagnosis early [0.03%]
查多克分期0期：综述及早期正确诊断的考虑因素
Crystal Holmes,Brian Schmidt,Michael Munson et al.
Crystal Holmes et al.
Charcot neuropathic osteoarthropathy (CN) is a rare disease (NIDDK, NIH Summary Report Charcot Workshop, 2008) that causes significant morbidity and mortality for affected patients. The disease can result in severe deformities of the foot a...
Total costs of basal or premixed insulin treatment in 5077 insulin-naïve type 2 diabetes patients: register-based observational study in clinical practice [0.03%]
5077例未曾使用过胰岛素的2型糖尿病患者中，基础或预混胰岛素治疗的总成本：来自真实世界临床实践的注册观察研究
Ann-Marie Svensson,Vincent Lak,MirNabi Pirouzi Fard et al.
Ann-Marie Svensson et al.
Background: To investigate the costs of treatment with basal insulin (insulin NPH [NPH], insulin glargine [IG], insulin determir [IG]), and premixed insulin (PM) in routine clinical care. ...